Literature DB >> 7583531

Oxidized LDL induces transcription factor activator protein-1 but inhibits activation of nuclear factor-kappa B in human vascular smooth muscle cells.

M P Ares1, B Kallin, P Eriksson, J Nilsson.   

Abstract

Oxidized LDL (Ox-LDL) has been implicated in the development of atherosclerotic lesions, mainly due to its enhanced uptake by macrophages and its ability to alter gene expression in arterial cells. In the present study we demonstrated that Ox-LDL activates activator protein-1 (AP-1), a transcription factor generally induced by mitogenic substances. Lysophosphatidylcholine, which is generated during oxidation of LDL, stimulated AP-1 in a dose-dependent manner. In contrast, the radical-dependent transcription factor nuclear factor-kappa B (NF-kappa B) was not activated by Ox-LDL, and at a concentration of 50 micrograms/mL, Ox-LDL inhibited lipopolysaccharide-induced activation of NF-kappa B. Oxysterols but not lysophosphatidylcholine inhibited lipopolysaccharide-induced NF-kappa B activation, suggesting that they may be responsible for the inhibitory effect of Ox-LDL. In conclusion, Ox-LDL has opposing effects on the activities of NF-kappa B and AP-1, suggesting involvement of mechanisms for transcriptional regulation that are strongly affected by lipid oxidation products.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7583531     DOI: 10.1161/01.atv.15.10.1584

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  8 in total

1.  Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages.

Authors:  B G Ohlsson; M C Englund; A L Karlsson; E Knutsen; C Erixon; H Skribeck; Y Liu; G Bondjers; O Wiklund
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Lysophosphatidylcholine activates transcription factor NF-kappaB and AP-1 in AR42J cells.

Authors:  A Masamune; Y Sakai; M Yoshida; A Satoh; K Satoh; T Shimosegawa
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

3.  Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes.

Authors:  S Caspar-Bauguil; J Tkaczuk; M J Haure; M Durand; J Alcouffe; M Thomsen; R Salvayre; H Benoist
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

Review 4.  Anti-inflammatory properties of lipid oxidation products.

Authors:  Valery N Bochkov; Norbert Leitinger
Journal:  J Mol Med (Berl)       Date:  2003-09-06       Impact factor: 4.599

5.  Complementary roles for scavenger receptor A and CD36 of human monocyte-derived macrophages in adhesion to surfaces coated with oxidized low-density lipoproteins and in secretion of H2O2.

Authors:  H Maxeiner; J Husemann; C A Thomas; J D Loike; J El Khoury; S C Silverstein
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

6.  Lysosomal oxidation of LDL alters lysosomal pH, induces senescence, and increases secretion of pro-inflammatory cytokines in human macrophages.

Authors:  Feroz Ahmad; David S Leake
Journal:  J Lipid Res       Date:  2018-11-05       Impact factor: 5.922

7.  Rotigotine protects against oxidized low-density lipoprotein(ox-LDL)-induced damages in human umbilical vein endothelial cells(HUVECs).

Authors:  Hui Kang; Hui Yu; Jingxiu Fan; Ge Cao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  Decreased inducibility of TNF expression in lipid-loaded macrophages.

Authors:  Mikko P S Ares; Maria Stollenwerk; Anneli Olsson; Bengt Kallin; Stefan Jovinge; Jan Nilsson
Journal:  BMC Immunol       Date:  2002-10-06       Impact factor: 3.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.